In April 2022, the FDA released draft guidance with recommendations for drug developers and clinical trial researchers. The guidance highlights gaps in equitable clinical trials and outlines the need for Race and Ethnicity Diversity Plans. Clinical trials are meant to ensure the safety and efficacy of a drug or medical device. Understanding...
Read More
Rare Disease Day will take place on February 29th this year and is a global opportunity to raise awareness for the individuals and families facing...
In the ever-evolving landscape of healthcare, a challenge persists – the unequal distribution, access, and quality of care for individuals. In...
Therapeutic innovation drives patient treatment updates and improves patient outcomes. From the development of chemotherapy to monoclonal antibody...
Payors are major stakeholders in the US healthcare system and shape patient access, health spending, and reimbursement. In this blog post, we will...
Beyond reviewing and approving drugs, the FDA plays a pivotal role in overseeing and approving medical devices, a realm defined by its innovation,...
In today's fast-paced world, where information overload is the norm, the need for evidence-based decision-making has never been greater. Systematic...
The recent approval of Narcan as an over-the-counter drug is a landmark decision that has the potential to save thousands of lives and highlights the...
Despite decades of advancement in medical research, disparities in women’s health continue to impact patient outcomes and quality of life. The White...
The journey from the research lab to a patient’s bedside for a drug is long, costly, and risky. Manufacturers make significant investments over many...
